(Q36906207)

English

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

scientific article published on 15 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

0 references

object named as

John M Lachin

8

0 references

Tadej Battelino

object named as

Tadej Battelino

4

0 references

Johnny Ludvigsson

object named as

Johnny Ludvigsson

6

0 references

Carla J Greenbaum

1

object named as

Carla J Greenbaum

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Thomas Mandrup-Poulsen

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Paula Friedenberg McGee

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Burkhard Haastert

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Paolo Pozzilli

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Hubert Kolb

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Type 1 Diabetes Trial Net Research Group

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

European C-Peptide Trial Study Group

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

15 July 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1966-1971

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

The role of measurement reliability in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

29 September 2017

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

29 September 2017

Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

27 June 2018

The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

4 September 2018

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

4 September 2018

Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

4 September 2018

Random C-peptide in the classification of diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2551636

4 September 2018

The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628574

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628574

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DC07-2451

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36906207&oldid=2088514007"